| Code | Description | Claims | Beneficiaries | Total Paid |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
882,128 |
767,488 |
$80.05M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
349,662 |
271,851 |
$16.30M |
| 80050 |
General health panel |
1,143,884 |
1,100,062 |
$15.34M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
473,991 |
368,035 |
$14.09M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
593,546 |
560,111 |
$9.45M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
592,788 |
558,295 |
$9.37M |
| 80061 |
Lipid panel |
1,498,388 |
1,433,703 |
$9.35M |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
757,576 |
726,287 |
$8.46M |
| 80053 |
Comprehensive metabolic panel |
1,669,027 |
1,453,650 |
$6.37M |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,234,745 |
1,182,053 |
$5.58M |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
247,585 |
243,562 |
$4.89M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,727,852 |
1,465,509 |
$4.31M |
| 84443 |
Thyroid stimulating hormone (TSH) |
664,758 |
618,959 |
$3.93M |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
283,277 |
273,011 |
$3.43M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
95,902 |
53,548 |
$3.21M |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
208,316 |
197,598 |
$3.12M |
| 87799 |
|
70,290 |
65,706 |
$2.98M |
| 36415 |
Collection of venous blood by venipuncture |
1,752,417 |
1,500,311 |
$2.69M |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
167,025 |
162,267 |
$2.64M |
| 82607 |
|
375,184 |
357,120 |
$2.64M |
| 80081 |
|
79,827 |
77,413 |
$2.56M |
| 86003 |
|
64,869 |
55,242 |
$2.22M |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
646,502 |
597,372 |
$2.13M |
| 80074 |
|
101,218 |
98,435 |
$2.06M |
| 84439 |
|
454,701 |
434,053 |
$1.92M |
| 81513 |
|
26,077 |
24,947 |
$1.77M |
| 82746 |
|
248,029 |
235,891 |
$1.72M |
| 86803 |
|
225,660 |
217,812 |
$1.69M |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
47,821 |
46,050 |
$1.68M |
| 86769 |
|
44,107 |
42,642 |
$1.61M |
| 87902 |
|
13,454 |
12,739 |
$1.60M |
| 84403 |
|
143,946 |
136,616 |
$1.59M |
| 83013 |
|
68,334 |
65,770 |
$1.55M |
| 82728 |
|
241,121 |
227,167 |
$1.43M |
| 86481 |
|
22,029 |
21,615 |
$1.31M |
| 87088 |
|
392,961 |
364,823 |
$1.29M |
| 83970 |
|
88,470 |
82,451 |
$1.25M |
| 87481 |
|
67,980 |
62,103 |
$1.22M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
26,680 |
26,207 |
$1.21M |
| 84153 |
|
145,194 |
138,459 |
$1.20M |
| 86480 |
|
56,237 |
53,859 |
$1.16M |
| 84481 |
|
152,303 |
145,796 |
$1.15M |
| 87522 |
Neg quan hep c or qual rna |
51,926 |
48,633 |
$1.12M |
| 87536 |
|
25,126 |
23,935 |
$1.08M |
| 86235 |
|
43,534 |
41,191 |
$1.06M |
| 87512 |
|
62,583 |
60,862 |
$978K |
| 81229 |
|
1,349 |
1,284 |
$958K |
| 82670 |
|
78,732 |
75,499 |
$949K |
| 84402 |
|
85,734 |
82,511 |
$890K |
| 88185 |
|
7,615 |
7,283 |
$863K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
7,780 |
7,631 |
$862K |
| 82570 |
|
420,303 |
389,443 |
$858K |
| 83550 |
|
224,992 |
212,073 |
$850K |
| 83540 |
|
276,309 |
260,602 |
$781K |
| 83001 |
|
88,956 |
85,407 |
$772K |
| 84146 |
|
84,411 |
79,917 |
$747K |
| 82043 |
|
311,955 |
296,466 |
$737K |
| 87081 |
|
256,614 |
246,209 |
$695K |
| 86038 |
|
111,433 |
105,717 |
$679K |
| 84702 |
|
104,828 |
85,340 |
$675K |
| 86696 |
|
72,180 |
66,405 |
$666K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
232,274 |
183,795 |
$661K |
| 83002 |
|
74,441 |
71,455 |
$639K |
| 87077 |
|
188,192 |
174,859 |
$623K |
| 83655 |
|
117,567 |
114,455 |
$618K |
| 87186 |
|
175,831 |
163,594 |
$618K |
| 86592 |
|
296,892 |
285,993 |
$605K |
| 88141 |
|
34,213 |
33,729 |
$605K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
10,167 |
8,678 |
$585K |
| 87340 |
|
142,360 |
136,623 |
$584K |
| 86635 |
|
63,306 |
57,488 |
$583K |
| 86140 |
|
232,574 |
200,329 |
$539K |
| 87660 |
|
66,115 |
63,261 |
$531K |
| 87480 |
|
66,130 |
63,394 |
$525K |
| 87510 |
|
65,865 |
63,055 |
$520K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
1,976 |
1,860 |
$498K |
| 83735 |
|
177,681 |
140,166 |
$470K |
| 86376 |
|
64,996 |
62,618 |
$447K |
| 82784 |
|
85,841 |
80,744 |
$438K |
| 81003 |
|
436,676 |
412,130 |
$428K |
| 86695 |
|
63,611 |
58,212 |
$400K |
| 85027 |
|
132,466 |
123,161 |
$370K |
| 82105 |
|
55,822 |
53,523 |
$365K |
| 86706 |
|
76,676 |
73,292 |
$364K |
| 84144 |
|
37,341 |
35,292 |
$361K |
| 88342 |
|
10,817 |
6,273 |
$358K |
| 83516 |
|
35,653 |
34,083 |
$352K |
| 82627 |
|
33,626 |
32,258 |
$336K |
| 86800 |
|
48,515 |
46,550 |
$329K |
| 83880 |
|
24,704 |
22,461 |
$326K |
| 86147 |
|
12,186 |
11,578 |
$325K |
| 80164 |
|
44,486 |
39,824 |
$314K |
| 86704 |
|
60,464 |
57,902 |
$313K |
| 84436 |
|
88,740 |
83,474 |
$306K |
| 88184 |
|
8,006 |
7,736 |
$306K |
| 85652 |
|
253,842 |
222,127 |
$304K |
| 86200 |
|
44,416 |
42,482 |
$294K |
| 86160 |
|
27,282 |
25,486 |
$285K |
| 86225 |
|
40,334 |
38,009 |
$278K |
| 82652 |
|
20,835 |
20,025 |
$273K |
| 82785 |
|
31,431 |
30,104 |
$263K |
| 86708 |
|
39,425 |
37,848 |
$257K |
| 86780 |
|
32,974 |
31,473 |
$254K |
| 81001 |
|
210,133 |
191,327 |
$250K |
| 84480 |
|
35,598 |
33,697 |
$248K |
| 83525 |
|
54,838 |
53,072 |
$243K |
| 84154 |
|
30,272 |
28,860 |
$240K |
| 85610 |
|
159,262 |
120,626 |
$234K |
| 80069 |
|
77,458 |
69,600 |
$232K |
| 86146 |
|
8,709 |
8,318 |
$227K |
| 84550 |
|
120,423 |
112,647 |
$222K |
| 84466 |
|
40,738 |
38,676 |
$218K |
| 88341 |
|
4,028 |
2,584 |
$213K |
| 82378 |
|
27,137 |
23,040 |
$212K |
| 82977 |
|
65,886 |
58,458 |
$207K |
| 86431 |
|
72,655 |
69,367 |
$207K |
| 83615 |
|
83,268 |
75,133 |
$205K |
| 80202 |
|
23,558 |
8,077 |
$198K |
| 81596 |
|
4,816 |
4,577 |
$198K |
| 86665 |
|
14,601 |
13,865 |
$195K |
| 87529 |
|
12,422 |
10,194 |
$193K |
| 87631 |
|
3,977 |
3,730 |
$190K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,347 |
1,320 |
$190K |
| 87070 |
|
57,342 |
53,742 |
$189K |
| 88112 |
|
10,238 |
5,782 |
$187K |
| 87901 |
|
1,553 |
1,478 |
$186K |
| 83690 |
|
54,851 |
52,192 |
$186K |
| 88312 |
|
5,666 |
3,306 |
$186K |
| 84681 |
|
21,822 |
20,988 |
$183K |
| 82533 |
|
25,304 |
23,357 |
$183K |
| 82950 |
|
86,680 |
84,382 |
$181K |
| 82248 |
|
82,300 |
73,298 |
$181K |
| 82024 |
|
13,084 |
12,293 |
$180K |
| 86364 |
|
22,709 |
20,002 |
$178K |
| 84445 |
|
9,176 |
8,862 |
$176K |
| 86360 |
|
13,174 |
12,637 |
$176K |
| 84100 |
|
106,090 |
82,028 |
$174K |
| 86300 |
|
17,260 |
15,048 |
$173K |
| 80076 |
|
60,190 |
56,112 |
$172K |
| 87209 |
|
21,092 |
19,928 |
$165K |
| 82672 |
|
17,058 |
16,521 |
$165K |
| 83520 |
|
21,710 |
20,131 |
$163K |
| 85730 |
|
57,163 |
53,554 |
$162K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
9,947 |
7,573 |
$161K |
| 84156 |
|
118,875 |
105,273 |
$161K |
| 88307 |
|
1,200 |
762 |
$159K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
13,348 |
11,426 |
$157K |
| 87625 |
|
11,533 |
11,080 |
$157K |
| 86361 |
|
12,371 |
11,736 |
$149K |
| 84425 |
|
15,939 |
15,140 |
$148K |
| 80197 |
|
29,304 |
18,062 |
$144K |
| 84479 |
|
45,212 |
42,403 |
$144K |
| 87338 |
|
23,389 |
22,584 |
$143K |
| 86762 |
|
21,104 |
20,233 |
$142K |
| 84270 |
|
15,425 |
14,774 |
$141K |
| 86359 |
|
12,904 |
12,389 |
$139K |
| 82274 |
|
21,483 |
20,793 |
$139K |
| 86141 |
|
23,164 |
21,929 |
$133K |
| 86787 |
|
23,290 |
21,706 |
$132K |
| 82550 |
|
44,171 |
38,159 |
$129K |
| 88189 |
|
2,760 |
2,639 |
$127K |
| 82150 |
|
39,429 |
37,582 |
$126K |
| 82677 |
|
10,089 |
9,752 |
$122K |
| 86304 |
|
13,354 |
11,839 |
$122K |
| 86258 |
|
14,673 |
12,375 |
$119K |
| 81206 |
|
1,679 |
1,578 |
$119K |
| 80055 |
|
5,745 |
5,593 |
$117K |
| 86334 |
|
11,609 |
10,632 |
$112K |
| 87517 |
|
7,491 |
7,066 |
$111K |
| 82951 |
|
24,319 |
23,634 |
$110K |
| 84165 |
|
23,287 |
21,577 |
$109K |
| 83014 |
|
30,907 |
30,055 |
$108K |
| 84432 |
|
13,970 |
13,399 |
$105K |
| 86850 |
|
43,278 |
41,386 |
$104K |
| 88142 |
|
8,046 |
7,834 |
$99K |
| 86705 |
|
23,094 |
22,203 |
$99K |
| 86039 |
|
16,737 |
15,905 |
$99K |
| 83498 |
|
8,637 |
8,370 |
$98K |
| 87497 |
|
6,668 |
4,086 |
$98K |
| 87147 |
|
50,175 |
48,261 |
$97K |
| 87427 |
|
18,265 |
17,518 |
$95K |
| 86317 |
|
14,359 |
12,756 |
$94K |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
21,629 |
20,143 |
$93K |
| 83921 |
|
12,785 |
12,036 |
$91K |
| 86255 |
|
15,099 |
13,364 |
$91K |
| 87900 |
|
1,482 |
1,417 |
$91K |
| 82140 |
|
15,990 |
13,487 |
$89K |
| 82088 |
|
5,568 |
5,267 |
$88K |
| 82247 |
|
40,188 |
33,454 |
$85K |
| 84207 |
|
7,953 |
7,616 |
$84K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,826 |
1,789 |
$83K |
| 87046 |
|
19,018 |
18,235 |
$83K |
| 88304 |
|
7,827 |
5,291 |
$82K |
| 87177 |
|
20,676 |
19,547 |
$81K |
| 86709 |
|
13,821 |
13,338 |
$80K |
| 85060 |
|
9,698 |
9,248 |
$78K |
| 84482 |
|
10,484 |
10,096 |
$78K |
| 87045 |
|
19,038 |
18,321 |
$78K |
| 83993 |
|
10,268 |
9,882 |
$77K |
| 86870 |
|
3,348 |
3,126 |
$77K |
| 86381 |
|
5,477 |
5,134 |
$75K |
| 87205 |
|
45,667 |
42,721 |
$75K |
| 86664 |
|
8,880 |
8,527 |
$75K |
| 83090 |
|
10,329 |
9,775 |
$74K |
| 84630 |
|
14,252 |
13,592 |
$74K |
| 84460 |
|
36,359 |
34,051 |
$71K |
| 86812 |
|
7,516 |
7,232 |
$71K |
| 80178 |
|
24,092 |
21,224 |
$68K |
| 88230 |
|
1,341 |
1,286 |
$67K |
| 86336 |
|
9,576 |
9,235 |
$67K |
| 83704 |
|
6,593 |
6,325 |
$66K |
| 82330 |
|
12,534 |
11,458 |
$63K |
| 82172 |
|
6,384 |
6,125 |
$63K |
| 87075 |
|
16,328 |
15,482 |
$62K |
| 88262 |
|
1,344 |
1,286 |
$62K |
| 84134 |
|
10,150 |
7,125 |
$62K |
| 84305 |
|
8,417 |
8,048 |
$61K |
| 84703 |
|
16,528 |
15,787 |
$61K |
| 82542 |
|
7,916 |
7,235 |
$61K |
| 81241 |
|
3,046 |
2,834 |
$59K |
| 86021 |
|
14,976 |
11,969 |
$59K |
| 82103 |
|
9,197 |
8,750 |
$59K |
| 82626 |
|
4,750 |
4,638 |
$58K |
| 86301 |
|
6,602 |
5,688 |
$57K |
| 81025 |
|
15,894 |
14,708 |
$57K |
| 82390 |
|
10,516 |
10,058 |
$57K |
| 87350 |
|
10,353 |
9,932 |
$56K |
| 84450 |
|
28,436 |
26,778 |
$55K |
| 0225U |
|
771 |
680 |
$54K |
| 86765 |
|
9,012 |
8,588 |
$53K |
| 86320 |
|
4,493 |
4,259 |
$53K |
| 87255 |
|
3,723 |
3,605 |
$53K |
| 86707 |
|
9,559 |
9,160 |
$52K |
| 86015 |
|
6,223 |
5,708 |
$52K |
| 80159 |
|
7,645 |
5,412 |
$52K |
| 84244 |
|
5,091 |
4,857 |
$49K |
| 86341 |
|
6,908 |
5,326 |
$48K |
| 82107 |
|
2,210 |
2,122 |
$48K |
| 82525 |
|
8,360 |
7,935 |
$48K |
| 86900 |
|
40,714 |
39,255 |
$48K |
| 82157 |
|
3,524 |
3,412 |
$48K |
| 86735 |
|
8,158 |
7,809 |
$47K |
| 86901 |
|
40,290 |
38,869 |
$47K |
| 83883 |
|
6,184 |
5,594 |
$47K |
| 87493 |
|
3,617 |
3,440 |
$47K |
| 85245 |
|
5,055 |
4,833 |
$46K |
| 82947 |
|
25,708 |
24,749 |
$46K |
| 85246 |
|
5,017 |
4,801 |
$46K |
| 85379 |
|
10,709 |
9,825 |
$46K |
| 85018 |
|
48,636 |
46,203 |
$45K |
| 83519 |
|
6,941 |
6,590 |
$45K |
| 83521 |
|
7,671 |
4,775 |
$45K |
| 84590 |
|
8,865 |
8,406 |
$43K |
| 82565 |
|
23,815 |
20,595 |
$43K |
| 36416 |
|
41,297 |
34,574 |
$42K |
| 80177 |
|
7,979 |
7,262 |
$41K |
| 87040 |
|
9,413 |
7,238 |
$40K |
| 85045 |
|
25,365 |
23,685 |
$40K |
| 84478 |
|
19,454 |
13,623 |
$40K |
| 85240 |
|
5,031 |
4,812 |
$39K |
| 80156 |
|
5,751 |
5,289 |
$38K |
| 82653 |
|
2,140 |
2,051 |
$38K |
| 85613 |
|
7,302 |
6,810 |
$38K |
| 81243 |
|
845 |
800 |
$38K |
| 87324 |
|
8,182 |
7,715 |
$37K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
377 |
363 |
$37K |
| 86645 |
|
4,115 |
3,910 |
$36K |
| 85014 |
|
40,780 |
38,604 |
$36K |
| 82668 |
|
4,138 |
3,844 |
$36K |
| 82952 |
|
20,131 |
19,558 |
$35K |
| 82530 |
|
4,806 |
3,858 |
$34K |
| 86738 |
|
3,440 |
3,348 |
$33K |
| 86335 |
|
3,405 |
3,188 |
$33K |
| 86644 |
|
4,245 |
4,009 |
$32K |
| 84166 |
|
3,974 |
3,714 |
$31K |
| 83021 |
|
4,661 |
4,521 |
$30K |
| 81270 |
|
949 |
871 |
$29K |
| 83010 |
|
5,874 |
5,412 |
$29K |
| 82040 |
|
16,846 |
15,755 |
$29K |
| 86593 |
|
11,847 |
11,231 |
$28K |
| 86036 |
|
1,968 |
1,904 |
$28K |
| 81240 |
|
1,991 |
1,864 |
$28K |
| 82787 |
|
2,792 |
2,608 |
$28K |
| 82610 |
|
5,231 |
4,949 |
$28K |
| 82985 |
|
7,091 |
6,788 |
$28K |
| 84155 |
|
21,589 |
20,075 |
$27K |
| 86060 |
|
7,199 |
6,882 |
$27K |
| 83835 |
|
3,876 |
3,508 |
$26K |
| 87329 |
|
5,270 |
5,068 |
$26K |
| 81256 |
|
1,415 |
1,322 |
$26K |
| 84378 |
|
9,148 |
8,680 |
$25K |
| 81015 |
|
20,737 |
19,767 |
$25K |
| 82731 |
|
1,572 |
1,462 |
$25K |
| 82397 |
|
4,613 |
4,424 |
$24K |
| 84520 |
|
18,506 |
16,590 |
$24K |
| 83630 |
|
2,834 |
2,718 |
$24K |
| 86617 |
|
1,930 |
1,854 |
$24K |
| 82310 |
|
14,556 |
13,185 |
$24K |
| 84075 |
|
13,517 |
12,654 |
$24K |
| 82232 |
|
3,447 |
3,150 |
$23K |
| 84446 |
|
4,584 |
4,354 |
$23K |
| 83020 |
|
4,448 |
4,287 |
$23K |
| 83695 |
|
3,891 |
3,744 |
$23K |
| 86162 |
|
2,473 |
2,363 |
$23K |
| 82085 |
|
5,255 |
4,986 |
$22K |
| 87102 |
|
6,715 |
6,344 |
$22K |
| 87563 |
|
1,569 |
1,470 |
$22K |
| 80175 |
|
3,865 |
3,695 |
$22K |
| 86357 |
|
1,273 |
1,218 |
$21K |
| 87210 |
|
6,102 |
5,805 |
$21K |
| 86355 |
|
1,246 |
1,199 |
$21K |
| 86777 |
|
2,573 |
2,431 |
$20K |
| 82104 |
|
2,982 |
2,890 |
$20K |
| 85306 |
|
2,742 |
2,622 |
$20K |
| 87511 |
|
2,338 |
2,185 |
$19K |
| 82679 |
|
1,821 |
1,753 |
$19K |
| 86337 |
|
1,729 |
1,659 |
$19K |
| 81207 |
|
293 |
277 |
$19K |
| 83698 |
|
1,799 |
1,719 |
$18K |
| 83003 |
|
2,356 |
2,113 |
$18K |
| 82384 |
|
2,038 |
1,844 |
$18K |
| 84163 |
|
4,013 |
3,887 |
$17K |
| 88291 |
|
1,671 |
1,559 |
$17K |
| 82747 |
|
2,358 |
2,227 |
$17K |
| 85303 |
|
2,507 |
2,420 |
$17K |
| 82465 |
|
10,837 |
10,380 |
$17K |
| 81479 |
Unlisted molecular pathology procedure |
62 |
56 |
$17K |
| 86615 |
|
2,201 |
2,014 |
$17K |
| 88173 |
|
356 |
189 |
$17K |
| 82164 |
|
2,770 |
2,695 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,198 |
2,102 |
$17K |
| 85007 |
|
12,359 |
11,382 |
$17K |
| 84255 |
|
2,374 |
2,245 |
$17K |
| 86663 |
|
2,630 |
2,544 |
$16K |
| 87254 |
|
1,504 |
1,443 |
$16K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
386 |
382 |
$16K |
| 86008 |
|
1,562 |
1,367 |
$16K |
| 80185 |
|
3,250 |
2,578 |
$15K |
| 87535 |
|
1,146 |
1,091 |
$15K |
| 80183 |
|
2,484 |
2,333 |
$15K |
| 82239 |
|
2,214 |
1,954 |
$15K |
| 86001 |
|
2,214 |
1,957 |
$15K |
| 83721 |
|
8,253 |
6,689 |
$14K |
| 82575 |
|
3,378 |
3,213 |
$14K |
| 84484 |
|
3,673 |
3,354 |
$14K |
| 85004 |
|
5,733 |
5,059 |
$14K |
| 80158 |
|
1,537 |
995 |
$14K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
155 |
129 |
$14K |
| 86671 |
|
1,904 |
1,696 |
$14K |
| 86231 |
|
1,167 |
1,121 |
$14K |
| 87109 |
|
1,735 |
1,654 |
$13K |
| 86148 |
|
3,620 |
2,484 |
$13K |
| 80051 |
|
5,110 |
4,818 |
$13K |
| 85300 |
|
2,187 |
2,103 |
$13K |
| 86308 |
|
4,496 |
4,347 |
$13K |
| 87015 |
|
5,150 |
4,757 |
$12K |
| 84080 |
|
2,206 |
2,109 |
$12K |
| 85384 |
|
3,306 |
3,033 |
$12K |
| 84132 |
|
6,917 |
6,156 |
$12K |
| 86316 |
|
1,624 |
1,518 |
$12K |
| 87184 |
|
4,517 |
4,279 |
$12K |
| 86774 |
|
1,718 |
1,647 |
$12K |
| 87269 |
|
2,506 |
2,395 |
$11K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
18,579 |
14,934 |
$11K |
| 86778 |
|
1,654 |
1,599 |
$11K |
| 87272 |
|
2,509 |
2,402 |
$11K |
| 82507 |
|
1,172 |
1,120 |
$11K |
| 81050 |
|
8,589 |
8,189 |
$11K |
| 87507 |
|
65 |
64 |
$11K |
| 84597 |
|
1,504 |
1,458 |
$11K |
| 80195 |
|
2,248 |
1,630 |
$11K |
| 80299 |
|
1,796 |
1,578 |
$11K |
| 85041 |
|
10,425 |
9,680 |
$11K |
| 82657 |
|
898 |
792 |
$10K |
| 83605 |
|
2,165 |
2,027 |
$10K |
| 82139 |
|
1,587 |
1,514 |
$10K |
| 85305 |
|
1,735 |
1,676 |
$10K |
| 87521 |
Neg quan hep c or qual rna |
642 |
616 |
$10K |
| 86618 |
|
1,140 |
1,110 |
$9K |
| 87116 |
|
2,550 |
2,277 |
$9K |
| 84140 |
|
1,133 |
1,094 |
$9K |
| 84300 |
|
4,852 |
4,525 |
$9K |
| 84442 |
|
966 |
949 |
$9K |
| 83935 |
|
3,546 |
3,280 |
$9K |
| 81291 |
|
739 |
689 |
$9K |
| 82671 |
|
668 |
638 |
$9K |
| 82379 |
|
1,630 |
1,557 |
$8K |
| 86256 |
|
1,482 |
1,404 |
$8K |
| 86694 |
|
1,050 |
1,039 |
$8K |
| 83718 |
|
2,531 |
2,404 |
$8K |
| 88313 |
|
434 |
216 |
$8K |
| 86077 |
|
557 |
532 |
$8K |
| 87076 |
|
2,123 |
2,013 |
$7K |
| 85048 |
|
7,276 |
6,173 |
$7K |
| 82664 |
|
557 |
541 |
$7K |
| 87906 |
|
128 |
122 |
$7K |
| 82175 |
|
802 |
754 |
$7K |
| 82340 |
|
2,940 |
2,808 |
$7K |
| 86702 |
|
1,362 |
1,227 |
$7K |
| 83876 |
|
939 |
882 |
$7K |
| 83631 |
|
860 |
817 |
$7K |
| 87206 |
|
3,776 |
3,295 |
$7K |
| 84145 |
|
1,102 |
944 |
$7K |
| 82552 |
|
1,234 |
1,172 |
$6K |
| 83945 |
|
1,265 |
1,204 |
$6K |
| 83930 |
|
2,606 |
2,429 |
$6K |
| 82308 |
|
702 |
676 |
$6K |
| 83527 |
|
1,161 |
1,122 |
$6K |
| 81332 |
|
329 |
305 |
$6K |
| 87300 |
|
1,106 |
1,067 |
$6K |
| 84295 |
|
3,838 |
3,078 |
$6K |
| 82365 |
|
1,205 |
1,173 |
$5K |
| 80203 |
|
1,098 |
1,037 |
$5K |
| 88271 |
|
314 |
286 |
$5K |
| 80180 |
|
755 |
643 |
$5K |
| 85247 |
|
675 |
640 |
$5K |
| 87107 |
|
1,194 |
1,129 |
$5K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
1,379 |
1,301 |
$5K |
| 81403 |
|
148 |
135 |
$5K |
| 85670 |
|
1,844 |
1,755 |
$5K |
| 80162 |
|
1,158 |
985 |
$5K |
| 85302 |
|
872 |
837 |
$5K |
| 85660 |
|
1,784 |
1,732 |
$5K |
| 86880 |
|
1,919 |
1,789 |
$5K |
| 85049 |
|
2,793 |
2,196 |
$5K |
| 86340 |
|
794 |
766 |
$5K |
| 86701 |
|
1,357 |
1,223 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
787 |
748 |
$4K |
| 87252 |
|
368 |
343 |
$4K |
| 82656 |
|
811 |
770 |
$4K |
| 83825 |
|
602 |
560 |
$4K |
| 82272 |
|
3,165 |
3,038 |
$4K |
| 83874 |
|
1,127 |
1,076 |
$4K |
| 88120 |
|
12 |
12 |
$4K |
| 81450 |
|
32 |
30 |
$4K |
| 86747 |
|
389 |
371 |
$4K |
| 84133 |
|
2,149 |
2,033 |
$4K |
| 82435 |
|
2,128 |
1,968 |
$4K |
| 83088 |
|
222 |
212 |
$4K |
| 82166 |
|
156 |
156 |
$4K |
| 82941 |
|
645 |
626 |
$4K |
| 84588 |
|
213 |
179 |
$4K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
66 |
66 |
$3K |
| 87280 |
|
608 |
595 |
$3K |
| 87140 |
|
1,285 |
1,231 |
$3K |
| 88275 |
|
242 |
216 |
$3K |
| 80165 |
|
709 |
651 |
$3K |
| 80201 |
|
657 |
620 |
$3K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
7,516 |
6,627 |
$3K |
| 84105 |
|
1,392 |
1,327 |
$3K |
| 87807 |
|
663 |
656 |
$3K |
| 81402 |
|
100 |
92 |
$3K |
| 84560 |
|
1,470 |
1,402 |
$3K |
| 84260 |
|
187 |
180 |
$3K |
| 82705 |
|
1,207 |
1,162 |
$3K |
| 82955 |
|
559 |
511 |
$3K |
| 80184 |
|
657 |
533 |
$3K |
| 83986 |
|
1,912 |
1,837 |
$2K |
| 87275 |
|
444 |
432 |
$2K |
| 86606 |
|
464 |
399 |
$2K |
| 82017 |
|
357 |
345 |
$2K |
| 87650 |
|
413 |
401 |
$2K |
| 87341 |
|
662 |
586 |
$2K |
| 86648 |
|
364 |
355 |
$2K |
| 82523 |
|
373 |
349 |
$2K |
| 86832 |
|
64 |
62 |
$2K |
| 82180 |
|
571 |
540 |
$2K |
| 82270 |
|
1,629 |
1,534 |
$2K |
| 87276 |
|
468 |
421 |
$2K |
| 84238 |
|
88 |
82 |
$2K |
| 84252 |
|
235 |
223 |
$2K |
| 85810 |
|
359 |
350 |
$2K |
| 83918 |
|
243 |
237 |
$2K |
| 88344 |
|
29 |
12 |
$2K |
| 89321 |
|
356 |
332 |
$2K |
| 82553 |
|
466 |
438 |
$2K |
| 87101 |
|
515 |
500 |
$2K |
| 89051 |
|
672 |
632 |
$1K |
| 84392 |
|
777 |
746 |
$1K |
| 80235 |
|
150 |
143 |
$1K |
| 88302 |
|
53 |
27 |
$1K |
| 86343 |
|
202 |
184 |
$1K |
| 86161 |
|
204 |
197 |
$1K |
| 85046 |
|
390 |
375 |
$1K |
| 84585 |
|
173 |
171 |
$1K |
| 87425 |
|
201 |
201 |
$1K |
| 81517 |
|
43 |
43 |
$1K |
| 84311 |
|
286 |
276 |
$908.20 |
| 89060 |
|
363 |
339 |
$868.88 |
| 86788 |
|
131 |
130 |
$843.56 |
| 81376 |
|
13 |
12 |
$758.60 |
| 81381 |
|
24 |
24 |
$754.52 |
| 81219 |
|
32 |
29 |
$746.59 |
| 87106 |
|
166 |
161 |
$744.76 |
| 86789 |
|
125 |
124 |
$720.44 |
| 86403 |
|
116 |
105 |
$699.17 |
| 86631 |
|
111 |
83 |
$681.20 |
| 87207 |
|
155 |
154 |
$671.89 |
| 85999 |
|
187 |
175 |
$641.57 |
| 83951 |
|
139 |
133 |
$631.02 |
| 87260 |
|
132 |
131 |
$620.13 |
| 86632 |
|
114 |
98 |
$608.23 |
| 88237 |
|
12 |
12 |
$519.24 |
| 86828 |
|
72 |
71 |
$505.16 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
62 |
47 |
$492.66 |
| 85055 |
|
44 |
43 |
$490.82 |
| 82595 |
|
229 |
212 |
$482.65 |
| 85301 |
|
97 |
95 |
$457.41 |
| 86682 |
|
44 |
43 |
$455.46 |
| 86833 |
|
27 |
25 |
$434.90 |
| 87279 |
|
165 |
149 |
$433.68 |
| 84143 |
|
28 |
28 |
$408.32 |
| 85520 |
|
46 |
36 |
$329.69 |
| 85307 |
|
48 |
41 |
$294.57 |
| 82945 |
|
154 |
150 |
$285.87 |
| 82540 |
|
128 |
120 |
$248.90 |
| 88264 |
|
12 |
12 |
$235.80 |
| 82010 |
|
93 |
91 |
$233.62 |
| 80186 |
|
35 |
28 |
$227.66 |
| 86790 |
|
28 |
28 |
$221.81 |
| 86710 |
|
29 |
28 |
$215.61 |
| 82681 |
|
14 |
14 |
$205.56 |
| 83497 |
|
42 |
40 |
$192.49 |
| 86611 |
|
28 |
28 |
$180.58 |
| 82374 |
|
245 |
181 |
$172.52 |
| 82495 |
|
30 |
28 |
$170.84 |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
382 |
256 |
$169.01 |
| 85732 |
|
27 |
26 |
$158.14 |
| 85250 |
|
30 |
25 |
$154.04 |
| 85576 |
|
12 |
12 |
$146.04 |
| 86005 |
|
318 |
233 |
$142.26 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
113 |
111 |
$125.77 |
| 87220 |
|
83 |
75 |
$113.61 |
| 81382 |
|
14 |
14 |
$108.21 |
| 86628 |
|
12 |
12 |
$102.37 |
| 99199 |
Unlisted special service, procedure or report |
3,972 |
2,894 |
$100.45 |
| 87273 |
|
14 |
12 |
$80.42 |
| 87176 |
|
43 |
40 |
$75.19 |
| 80169 |
|
24 |
12 |
$68.97 |
| 88164 |
|
12 |
12 |
$58.88 |
| 87110 |
|
12 |
12 |
$49.89 |
| 87265 |
|
13 |
13 |
$47.50 |
| 86886 |
|
13 |
12 |
$37.72 |
| 87185 |
|
13 |
13 |
$26.74 |
| 82436 |
|
12 |
12 |
$8.84 |
| 81508 |
|
296 |
286 |
$0.00 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
32 |
31 |
$0.00 |
| 99001 |
|
17 |
15 |
$0.00 |